Evidence map›Paper›PMID 31290529›Full record

ArticleLab on a chip2019

Clinical translation of microfluidic sensor devices: focus on calibration and analytical robustness.

Sally A N Gowers, Michelle L Rogers, Marsilea A Booth, Chi L Leong, Isabelle C Samper, Tonghathai Phairatana, Sharon L Jewell, Clemens Pahl, Anthony J Strong, Martyn G Boutelle

Abstract read
In one paragraph

Article in Lab on a chip, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Dexamethasone-Enhanced Microdialysis and Penetration Injury.Frontiers in bioengineering and biotechnology · 2020
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sally A N GowersDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk.ORCID 0000-0002-2407-2266
Michelle L RogersDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk.ORCID 0000-0002-1434-2322
Marsilea A BoothDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk.
Chi L LeongDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk.
Isabelle C SamperDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk.ORCID 0000-0003-2596-954X
Tonghathai PhairatanaDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk and Institute of Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.
Sharon L JewellDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk.
Clemens PahlDepartment of Basic and Clinical Neuroscience, Kings College London, UK.
Anthony J StrongDepartment of Basic and Clinical Neuroscience, Kings College London, UK.
Martyn G BoutelleDepartment of Bioengineering, Imperial College London, UK. m.boutelle@imperial.ac.uk.ORCID 0000-0003-1332-3442

Funding

Enhanced Bedside Microdialysis for TBIR01NS102725 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MICHAEL, ADRIAN C, PUCCIO, AVA M. · 2018 to 2022
$2.7M
Technical enhancements for intracranial microdialysisR21NS109875 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MICHAEL, ADRIAN C · 2018 to 2019
$401k
Medical Research Council MR/R00112X/1NINDS NIH HHS R01 NS102725NINDS NIH HHS R21 NS109875Wellcome Trust
6 · The paper itself

Abstract

We present approaches to facilitate the use of microfluidics outside of the laboratory, in our case within a clinical setting and monitoring from human subjects, where the complexity of microfluidic devices requires high skill and expertise and would otherwise limit translation. Microfluidic devices show great potential for converting complex laboratory protocols into on-chip processes. We demonstrate a flexible microfluidic platform can be coupled to microfluidic biosensors and used in conjunction with clinical microdialysis. The versatility is demonstrated through a series of examples of increasing complexity including analytical processes relevant to a clinical environment such as automatic calibration, standard addition, and more general processes including system optimisation, reagent addition and homogenous enzyme reactions. The precision and control offered by this set-up enables the use of microfluidics by non-experts in clinical settings, increasing uptake and usage in real-world scenarios. We demonstrate how this type of system is helpful in guiding physicians in real-time clinical decision-making.

Indexed as

Lab-On-A-Chip DevicesTranslational Research, BiomedicalBiosensing TechniquesBrain Injuries, TraumaticCalibrationEnzymes, ImmobilizedMicrodialysisEnzymes, Immobilized

Identifiers

PMID31290529
PMCPMC7321805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.